{
    "title": "Regeneron's antibody drug added to UK Recovery trial of COVID treatments",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8730699/Regenerons-antibody-drug-added-UK-Recovery-trial-COVID-treatments.html",
    "date": "2020-09-14",
    "keywords": [
        "trial",
        "antibody",
        "covid19",
        "drug",
        "cocktail",
        "recovery",
        "regeneron",
        "regncov2",
        "disease",
        "medicine",
        "kate",
        "kelland",
        "landray",
        "treatment",
        "roche",
        "month",
        "reporting",
        "range",
        "april",
        "care",
        "professor",
        "amp",
        "epidemiology",
        "university",
        "interview",
        "addition",
        "number",
        "june",
        "dexamethasone",
        "hydrocortisone",
        "death",
        "hydroxychloroquine",
        "president",
        "trump",
        "game",
        "changer",
        "pandemic",
        "benefit",
        "company",
        "regeneronmade",
        "combination",
        "spike",
        "protein",
        "coronavirus",
        "access",
        "viruss",
        "ability",
        "manufacturing",
        "capacity",
        "demand",
        "world",
        "team",
        "supply",
        "phase",
        "time",
        "deal",
        "place",
        "prevention",
        "eli",
        "firm",
        "abcellera",
        "contender",
        "race",
        "august",
        "compound",
        "covid",
        "september",
        "glaxosmithkline",
        "partner",
        "vir",
        "biotechnology",
        "astrazeneca",
        "tolerability",
        "beasley",
        "john",
        "miller",
        "burger",
        "fenton"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}